Inovio Pharmaceuticals, Inc.
VACCINES HAVING AN ANTIGEN AND INTERLEUKIN-21 AS AN ADJUVANT

Last updated:

Abstract:

Disclosed herein is a vaccine comprising an antigen and IL-21. Also disclosed herein are methods for increasing an immune response in a subject. The methods may comprise administering the vaccine to the subject in need thereof.

Status:
Application
Type:

Utility

Filling date:

15 Apr 2021

Issue date:

5 Aug 2021